Ubs Group Ag Voyager Therapeutics, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 24,263 shares of VYGR stock, worth $130,049. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,263

Previous 58,492 58.52%

Holding current value

$130,049

Previous $462,000 69.48%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.77 - $9.27 $197,501 - $317,302	-34,229 Reduced 58.52%	24,263 $141,000
Q2 2024 Aug 13, 2024	SELL	$7.42 - $10.54 $339,776 - $482,647	-45,792 Reduced 43.91%	58,492 $462,000
Q1 2024 May 13, 2024	BUY	$7.15 - $10.84 $511,868 - $776,035	71,590 Added 218.97%	104,284 $970,000
Q4 2023 Feb 09, 2024	BUY	$6.28 - $8.81 $116,399 - $163,293	18,535 Added 130.91%	32,694 $275,000
Q3 2023 Nov 09, 2023	SELL	$7.55 - $11.25 $88,168 - $131,377	-11,678 Reduced 45.2%	14,159 $109,000
Q2 2023 Aug 11, 2023	BUY	$6.94 - $13.99 $144,247 - $290,782	20,785 Added 411.42%	25,837 $295,000
Q1 2023 May 12, 2023	BUY	$6.0 - $10.78 $30,312 - $54,460	5,052 New	5,052 $38,000
Q3 2022 Nov 10, 2022	BUY	$5.57 - $7.47 $13,880 - $18,615	2,492 Added 1181.04%	2,703 $16,000
Q2 2022 Aug 10, 2022	SELL	$4.82 - $10.09 $18,865 - $39,492	-3,914 Reduced 94.88%	211 $1,000
Q1 2022 May 16, 2022	SELL	$2.75 - $9.44 $6,952 - $23,864	-2,528 Reduced 38.0%	4,125 $31,000
Q4 2021 Feb 14, 2022	SELL	$2.47 - $5.55 $449,213 - $1.01 Million	-181,868 Reduced 96.47%	6,653 $18,000
Q3 2021 Nov 15, 2021	BUY	$2.63 - $4.12 $111,569 - $174,778	42,422 Added 29.04%	188,521 $496,000
Q2 2021 Aug 13, 2021	BUY	$3.94 - $5.44 $14,239 - $19,660	3,614 Added 2.54%	146,099 $603,000
Q1 2021 May 12, 2021	BUY	$4.61 - $9.04 $514,157 - $1.01 Million	111,531 Added 360.31%	142,485 $672,000
Q4 2020 Feb 11, 2021	BUY	$7.15 - $12.28 $209,380 - $359,607	29,284 Added 1753.53%	30,954 $221,000
Q3 2020 Nov 12, 2020	SELL	$10.01 - $13.75 $38,238 - $52,525	-3,820 Reduced 69.58%	1,670 $18,000
Q2 2020 Jul 31, 2020	BUY	$8.05 - $14.21 $34,534 - $60,960	4,290 Added 357.5%	5,490 $69,000
Q1 2020 May 01, 2020	SELL	$6.8 - $14.66 $62,566 - $134,886	-9,201 Reduced 88.46%	1,200 $11,000
Q4 2019 Feb 14, 2020	SELL	$12.82 - $16.85 $1.11 Million - $1.45 Million	-86,264 Reduced 89.24%	10,401 $145,000
Q3 2019 Nov 14, 2019	BUY	$16.31 - $28.29 $1.19 Million - $2.07 Million	73,173 Added 311.48%	96,665 $1.66 Million
Q2 2019 Aug 14, 2019	BUY	$19.18 - $27.88 $379,054 - $550,992	19,763 Added 529.98%	23,492 $640,000
Q1 2019 May 14, 2019	BUY	$8.0 - $19.66 $13,768 - $33,834	1,721 Added 85.71%	3,729 $71,000
Q4 2018 Feb 14, 2019	BUY	$8.59 - $18.05 $14,671 - $30,829	1,708 Added 569.33%	2,008 $19,000
Q3 2018 Nov 14, 2018	SELL	$17.11 - $21.74 $3,422 - $4,348	-200 Reduced 40.0%	300 $6,000
Q2 2018 Aug 14, 2018	SELL	$16.76 - $23.92 $601,265 - $858,130	-35,875 Reduced 98.63%	500 $10,000
Q1 2018 May 15, 2018	BUY	$16.16 - $31.31 $587,820 - $1.14 Million	36,375 New	36,375 $684,000
Q4 2017 Feb 14, 2018	SELL	$12.26 - $25.88 $9,452 - $19,953	-771 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$8.37 - $20.59 $6,453 - $15,874	771 New	771 $16,000
Q2 2017 Aug 14, 2017	SELL	N/A	-745 Closed	0 $0
Q1 2017 Nov 14, 2017	BUY	N/A	745	745 $10,000

Others Institutions Holding VYGR

# of Institutions

130

Shares Held

34.7M

Call Options Held

39.7K

Put Options Held

34.6K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $207M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account